Curiox China Terminates ₩2.7bn HT and Buffer Exchanger Equipment Sales Contract

Curiox Biosystems · KOSDAQ · 445680 · Oct 29, 2026 · Supply contracts

Curiox Biosystems filed notice that it terminated an equipment sales contract with its subsidiary Curiox Biosystems China Co., Ltd., effective Oct 29, 2026. The terminated contract amount was ₩2.7bn, reported as 37.6% of revenue. The company stated that it received an official letter from the upstream contractor saying performance of the contract was impossible.

Key facts

EventContract terminated
Contract nameHT and Buffer Exchanger equipment sales contract
CounterpartyCuriox Biosystems China Co., Ltd.
Terminated contract amount₩2.7bn
% of revenue (as reported)37.6%
Reason for terminationReceived an official letter from the upstream contractor Hunan Deshengyuan Biotechnology Co., Ltd. stating that performance of the contract is impossible
Termination dateOct 29, 2026

Comparison

Amount as % of FY2025 revenue (calculated)52.8%
Revenue 2025₩5.2bn
Revenue 2024₩4.6bn
Revenue 2023₩6.8bn

Context

By our calculation, the terminated contract amount is 52.8% of FY2025 revenue.

Key metrics

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)